Citadel Advisors »

Homology Medicines shares owned by Citadel Advisors

Quarter-by-quarter ownership of Homology Medicines shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Homology Medicines

Tip: Access up to 7 years of quarterly data

All positions including Homology Medicines held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Homology Medicines by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $44k 73k 0.61
2023-09-30 $1.0M 882k 1.17
2023-06-30 $661k 747k 0.89
2023-03-31 $957k 929k 1.03
2022-12-31 $1.4M 1.1M 1.26
2022-06-30 $2.1M 1.1M 1.97
2022-03-31 $1.4M 473k 3.04
2021-12-31 $867k 238k 3.64
2021-09-30 $695k 88k 7.86
2021-06-30 $678k 93k 7.29
2021-03-31 $739k 79k 9.41
2020-12-31 $12M 1.0M 11.30
2020-09-30 $908k 85k 10.70
2020-06-30 $647k 43k 15.20
2020-03-31 $261k 17k 15.21
2019-12-31 $0 23k 0.00
2019-09-30 $13M 733k 18.10
2019-06-30 $815k 42k 19.31
2018-06-30 $329k 16k 20.48
2018-03-31 $472k 25k 18.72